Rett syndrome in the therapeutic era: Rethinking diagnosis, boundaries, clinical outcomes, and financing
Developmental Medicine & Child Neurology · 04.09.2026
DOI: 10.1111/dmcn.70516 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 04.09.2026. Verfasst von Walter E Kaufmann. Beteiligte Einrichtung: Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben.
Abstract (Originalsprache)
Rett syndrome (RTT) is a severe neurodevelopmental disorder characterized by multiple neurological impairments, which affects predominantly females. It is associated, in most cases, with pathogenic variants in MECP2 , the gene encoding the methyl‐CpG‐binding protein 2. In the four decades since its description in the English literature, the RTT field has seen major progress in the understanding of its genetics, neurobiology, and clinical evolution. These have led to the first drug approved for core symptoms of a neurodevelopmental disorder, trofinetide, and gene replacement programs at advanced development. These achievements have brought new challenges and highlighted unresolved issues. These include diagnosis before developmental regression and of individuals without core RTT features, including males; the role of MECP2 testing in RTT diagnosis; the boundaries of RTT; instruments needed for assessing clinical evolution in research and practice; the definition of meaningful clinical improvement; and the development, availability, and affordability of new treatments. These topics are reviewed in terms of their implications for RTT and for other genetic neurodevelopmental disorders.
Autor:innen und Institutionen
- Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.
- Department of Neurology, Boston Children's Hospital, Boston, MA, USA.
ORCID-Profile: Walter E Kaufmann
Zitieren
APA
Kaufmann, W. E. (2026). Rett syndrome in the therapeutic era: Rethinking diagnosis, boundaries, clinical outcomes, and financing. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.70516
Vancouver
Kaufmann WE. Rett syndrome in the therapeutic era: Rethinking diagnosis, boundaries, clinical outcomes, and financing. Developmental Medicine & Child Neurology. 2026. doi:10.1111/dmcn.70516
BibTeX
@article{Kaufmann2026,
author = {Kaufmann, Walter E},
title = {Rett syndrome in the therapeutic era: Rethinking diagnosis, boundaries, clinical outcomes, and financing},
journal = {Developmental Medicine & Child Neurology},
year = {2026},
doi = {10.1111/dmcn.70516}
}
EUVIMED